🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Recruitingn/aAges any - anyAllIcahn School of Medicine at Mount Sinai
NCT04199000 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals with a genetically, enzymatically, or molecularly confirmed diagnosis of CDG or NGLY1 deficiency Exclusion Criteria: * None
💊

What it tests

  • Not listed
📍

Where

12 sites
Rady Children's Hospital
San Diego, United States
Children's Hospital of Colorado
Aurora, United States
Mayo Clinic Florida
Jacksonville, United States
Tulane University School of Medicine
New Orleans, United States
Boston Children's Hospital
Boston, United States
University of Minnesota
Minneapolis, United States
Mayo Clinic in Rochester
Rochester, United States
Icahn School of Medicine at Mount Sinai
New York, United States

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy